Loss of p16 in advanced stage epithelial ovarian cancer is associated with chemoresistant disease, suboptimal debulking and poor progression-free survival: A Gynecologic Oncology Group study.
作者
Andrew J. Wallace,Kathleen M. Darcy,A. Alvarez-Secord,Alan D. Hutson,David Tritchler,L. Kirchgraber,L. Grace,Regina S. Whitaker,Andrew Berchuck,Laura J. Havrilesky